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Abstract 
The time and cost benefits of miniaturized fermentation platforms can only be gained by 
employing complementary techniques facilitating high-throughput at small sample volumes.  
Microbial cell disruption is a major bottleneck in experimental throughput and is often 
restricted to large processing volumes. Moreover, for rigid yeast species such as Pichia 
pastoris, no effective high-throughput disruption methods exist.  
This study describes the development of an automated, miniaturized, high-throughput, non-
contact, scalable platform based on Adaptive Focused Acoustics (AFA) to disrupt P. pastoris 
and recover intracellular heterologous protein. 
Augmented modes of AFA were established by investigating vessel designs and a novel 
enzymatic pre-treatment step. Three different modes of AFA were studied and compared to 
the performance high pressure homogenization. For each of these modes of cell disruption, 
response models were developed to account for five different performance criteria. Using 
multiple responses not only demonstrated that different operating parameters are required for 
different response optima, with highest product purity requiring suboptimal values for other 
criteria, but also allowed for AFA-based methods to mimic large-scale homogenization 
processes.  
These results demonstrate that AFA-mediated cell disruption can be used for a wide range of 
applications including buffer development, strain selection, fermentation process 
development and whole bioprocess integration. 
Keywords  
Pichia pastoris, scale-down, high-throughput, Adaptive Focused Acoustics, cell disruption, 
homogenization 
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Introduction 
Scale-down bioprocesses form the backbone of rapid bioprocess design, allowing for cost-
effective and rapid development of biopharmaceutical production processes. Specifically, 
small-scale fermentation process design combined with multivariate data analysis techniques 
and subsequent process up-scaling has proven to be effective for characterizing and 
optimizing industrial-scale operations 
1–4
.  
Pichia pastoris, recently reassigned to the genus Komagataella, is a methanol assimilating 
yeast that has been receiving increased industrial attention over the past two decades due to 
its potential to produce a wide array of complex biopharmaceuticals 
5–12
.  
P. pastoris offers the potential of heterologous protein secretion, however depending on 
physical and chemical properties of the protein of interest, this is not always a viable option 
13,14
. In this alternative scenario, the product of interest needs to be liberated from the interior 
of the cell through a disruption process.  
A widely-used method of cell disruption in microbial bioprocessing is High Pressure 
Homogenization (HPH). This method involves passing a cell suspension at high pressure, and 
often low temperature to mitigate heat effects, through an adjustable valve with a restricted 
cavity. Through high velocity impact, cavitation, fluid shear and decompression the cells are 
disrupted causing their contents to be released in the media. This process can be repeated for 
several passes increasing the levels of cell disruption and debris generated 
15,16
. Overall cell 
disruption can be described with the following equation 
17
:  
  	 = 
  (1) 
Where, Rmax is the maximum amount of releasable protein, R the observed amount of released 
protein, N the discrete number of passes through the valve, k a temperature dependent rate 
constant and is specific to the organism being disrupted; p the operating pressure and α is a 
measure of a microbe’s resistance to disruption. In addition, efficiency of homogenization is 
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known to decrease at high biomass suspension concentrations 
18
. Therefore, for a given 
organism harvested at fixed conditions the following relation can be observed for cell 
disruption: 
 = (, , [])   (2) 
Where [X] is the concentration of biomass in suspension. 
However, high pressure homogenization is only suitable for processing large volumes with 
the smallest representative size being 40mL using an APV Gaulin Lab40 homogenizer 
19
.  
Scale-down bioprocess sequences often start with the use of microtiter plates or miniaturized 
bioreactors 
20,21
.  HPH therefore remains an incompatible platform for scale-down 
bioprocesses, as sample volumes are often in the microliter range. 
Small-scale cell disruption of yeasts has often been achieved using bead lysis methods
22
. 
However limitations of bead-mediated lysis include the requirement of additional process 
bottlenecks demanding the removal of beads from lysate, poor temperature control, lower 
process reproducibility due to a requirement of bead size uniformity, loss of product due to 
residual volume after sample processing and high surface-to-volume ratios which could lead 
to adhesion of cellular material
23
.   
Adaptive Focused Acoustics (AFA) has shown to be a suitable miniaturized platform for the 
disruption of the yeast, Saccharomyces cerevisiae 
24
. An AFA device generates acoustic 
shock waves in the kilohertz (KHz) region. These sonic waves cause controlled cavitation at 
a focal point within the sample vessel 
25
. The device can process up to 12-96 samples in a 
batch, enabling rapid, high-throughput, non-contact cell disruption. Figure 1 explains the 
operating parameters associated with the Covaris E210. Process variables contributing to cell 
disruption can be described as follows: 
 = (, , , , [])  (3) 
Duty Factor, DF (%), refers to the relative time between sonic bursts, hence 
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 =    ∙ "".   (4) 
Intensity, I (mV), denotes the amplitude of the sonic wave. Cycles per burst, cpb, refers to the 
amount of cycles per acoustic wave. Time, t (s), refers to the total acoustic exposure time. [X] 
(g/L) refers to the wet cell biomass concentration in suspension. Although there are studies 
showing promising results for extracting intracellular product from S. cerevisiae, no 
extensive studies exist for AFA-mediated cell disruption of P. pastoris.  
This study examined AFA-mediated cell disruption of P.pastoris (KM71h) with the Covaris 
E210 series to liberate Tandem Core Hepatitis B core Virus-Like Particles (TC-HBc VLPs) 
described by 
26
. After screening for significant factors, three AFA experiments were 
performed to generate Response Surface Models (RSMs) to account for changes in vessel 
design and enzymatic pre-treatment of samples. This data was subsequently compared to 
large-scale performance by generating RSMs for HPH-based cell disruption.  
To choose appropriate responses to generate RSMs, performance criteria had to be defined. 
Most studies have only defined total soluble protein content as a performance criteria of cell 
disruption processes. However, maximizing cell disruption is not always the main objective 
of cell disruption. This study has outlined data with five different performance criteria and 
generated RSMs for each criterion, for each experiment: (1) Total cell disruption, measured 
as the concentration of total soluble protein, R (mg/mL), (2) specific cell disruption, defined 
as the amount of protein released per unit of suspended biomass, Rs (mg/gWCW), (3) total 
product recovery expressed as the concentration of soluble Tandem Core Hepatitis B core 
protein [TC-HBc] (µg/mL), (4) specific product recovery, TC-HBcs (µg/gWCW) and (5) 
product purity, expressed as a ratio of total recover product relative to the amount of total 
release soluble protein, P (%). By understanding the response models of multiple 
performance criteria, this study aimed to broaden the range applications of AFA-mediated 
cell disruption as well as create a performance-based scaling method for cell disruption. 
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Materials and Methods 
All chemical and reagents were purchased from Sigma-Aldrich (Gillingham, UK) unless 
stated otherwise. 
Process Overview  
Figure 2 depicts a summary of the unit operations involved in experimental methods in this 
series of studies. Note that only unit operations “C” were varied in this study. The responses 
(R, Rs, [TC-HBc], TC-HBcs, P) of these variations were measured after the second 
centrifugation step post lysis, “E”. Material for further qualitative analysis was fractioned 
prior to unit operation “D”. 
Pichia pastoris Cell Engineering and Fermentation  
A transformed Pichia pastoris strain of the Mut
S
 phenotype (KM71h) was provided by iQur 
Ltd, (London, UK). Upon induction, this strain expressed Tandem Core HBc protein with 
single lysine amino acids inserts displayed on its two insertion regions.   
Invitrogen’s fermentation protocol
27
 for Pichia pastoris Mut
S
 strains was used to generate 
experimental material in a 30L BIOSTAT Cplus bioreactor (Sartorius Stedim, Epsom UK). 
The reactor was filled with 11.5L Basal Salts Medium to achieve a total starting working 
volume of 12L post-inoculation. Details of this procedure are described below. 
For seed culture, 2 x 250mL of Buffer Glycerol-complex BMGY medium
28
 was inoculated 
with 1.8 mL cell bank culture [BMGY culture, 30%vol glycerol, optical density 
A600nm=25.0] in 2L baffled Nalgene shakeflasks. After 16 hours, the absorbance at 
600nm of the seed culture was 20-30 relative absorbance units.  A variable fraction of the 
culture was centrifuged at 3200 g, 20°C, 10 min and resuspended in 500mL Basal Salts 
Medium to achieve defined conditions and a starting bioreactor inoculation optical density of 
1 absorbance unit at 600nm.  
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The bioreactor was run in batch-mode after inoculation. The Dissolved Oxygen Tension 
(DOT) setpoint was set at 30% and was controlled in a sequence cascade by agitating the 
impeller between 468 to 1123 rpm followed by oxygen gas blending in ratio mode at a 
constant volumetric gas flowrate of 0.25vvm. pH range was maintained between 4.75-5.0 and 
pre-induction temperature at 30±0.1°C. A 20% drop in Carbon Evolution Rate (CER) and 
spike in DOT, indicating depletion of carbon source, triggered a fed-batch glycerol feed. This 
was generally observed between 18-20 hours after bioreactor inoculation. This glycerol fed-
batch phase was maintained for a fixed 4 hours at a constant flow rate of 18.15 milliliters per 
liter initial working volume per hour (mL/Li/h). 20 minutes prior to the induction phase the 
temperature setpoint was adjusted to 25°C. The end of the glycerol fed-batch phase triggered 
the methanol induction phase. For the first two hours of the induction phase the methanol 
flow rate was kept constant at 1mL/Li/h. After this the feed rate was increased by 10% 
increments every 30 minutes until a target feed rate of 5.5mL/Li/h was reached.  
After 40 hours of induction the culture was cooled to 12°C to minimize proteolytic activity. 
Fermentation broth was harvested at 3000 g, 20 min and 4°C.  The wet pellets were weighed 
and stored at -20°C.  
Cell Disruption and Primary Recovery 
Lysis Reagents  
MOPS lysis buffer: 50mM 3-(N-morpholino)propanesulfonic acid (MOPS), (1mM 4-(2-
aminoethyl) benzenesulfonyl fluoride (AEBSF) hydrochloride, 5U/mL benzonase (Cat. No. 
E8263-25KU), 5mM dithiothreitol (DTT) in reverse osmosis water titrated with 1M sodium 
hydroxide to achieve a of pH 7.5 (at 10°C). EDTA stock solution: 500mM 
Ethylenediaminetetraacetic acid tri-sodium salt in RO water. Triton-X100 stock solution: 
10% vol. Triton-X100 in RO water. Lyticase stock solution: 2000U/mL lyticase from 
Arthrobacter luteus (Cat. No. L2524), 100mM potassium phosphate, 100mM sodium 
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hydroxide, 50% vol. glycerol, pH 7.5 in RO water. MOPS Enzymatic lysis buffer: 4% vol. 
lyticase stock solution and 1% vol. Triton-X100 stock solution in MOPS lysis buffer.  
High Pressure Homogenization Optimization 
Frozen cell paste was weighed and resuspended in lysis buffer to achieve wet cell weight 
(WCW) concentrations of 50, 75 and 100 g/L. 40mL aliquots were prepared and 
subsequently disrupted using a APV Gaulin Lab40 high pressure homogenizer at 300, 750 
and 1200 bar, for 1, 3 and 5 passes. Homogenization was performed at T<10°C with the aid 
of a glycol cooling loop. 
To each homogenized sample a 1% volumetric addition of Triton X-100 stock solution was 
added to facilitate protein release. After a one-hour incubation period at 4°C a 1% volumetric 
addition of EDTA stock solution was added to each aliquot. 1 mL from each aliquot was 
collected for clarification and subsequent analysis. 
Adaptive Focused Acoustics Characterization  
The Covaris E210 was used to perform AFA-mediated cell disruption. Experiments were 
conducted with 1mL cell suspensions in MOPS lysis buffer, 0.1% Triton X-100, in 12 x 
12mm milliTUBE vials, each containing an integrated fiber to assist disruption. The tubes 
were secured in a 4 x 6 rack. The rack was placed into the water bath of the Covaris system 
containing degassed water at a temperature of 10 ± 1°C and a submerged acoustic transducer. 
Cell disruption was performed in power tracking mode, automatically by placing each tube in 
a predetermined sequence in the focal zone of the transducer. A 1% volumetric addition of 
EDTA stock solution was added after sonication.  
A two-level, half-fractional, 5-factorial design with four center points was used to screen for 
factors significantly contributing to Root Mean Square Error (RMSE). This screening was 
followed by a two-level, full-fractional, 4-factorial design screening with four center points to 
study the effect of time at shorter range when biomass concentration was fixed.  
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Lyticase treatment  
MOPS Enzymatic Lysis buffer was heated in a bath to 25°C. Frozen cell paste was 
resuspended in the warmed buffer to a target biomass value, followed by a 1 hour incubation 
at 25°C.  
Adaptive Focused Acoustics Optimization  
After determining significant factors using the half-fractional design described in a previous 
section, three experiments were performed to generate RSMs to account for (1) vial design 
and (2) to investigate if performance could be augmented using an enzymatic pre-treatment 
step described in the previous section. In these three experiments, sonication time as an 
operating factor was fixed at 60 seconds, as screening beyond this time was shown to have 
very little effect. 
The first experiment used 6mL Chromacol tubes in which 1mL samples were sonicated, the 
second experiment used the previously mentioned 1mL milliTUBEs in which 1mL samples 
were sonicated and the third experiment involved the use of 1mL milliTUBEs in which 1mL 
enzymatically pre-treated samples were sonicated.  
For each experiment five RSMs were generated as discussed in the end of the introduction 
section. 
Clarification 
Lysates were centrifuged at 4°C and 15000 g for 30 minutes using a benchtop Eppendorf 
Centrifuge (model 5415R). The supernatant of each sample was filtered with a 0.22µm 
33mm Millex PVDF syringe filter (Merck Millipore; Billerica MA, USA).  Filtrate was 
stored at 4-7°C for up to one week until further analysis. 
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Analytical methods 
Screening and Response Surface Methodology  
All statistical analysis and model generation was done using JMPPro12.0.1 (SAS Institute 
Incorporation; Cary NC, USA). 
Screening models were generated with a minimum resolution of 5 to estimate all possible 
two-factor interactions. The relative contribution of an individual factor was defined as the 
total of the sum of squares (Type III) of each factor-associated term as a percentage of the 
total of the sum of squares of all terms in the screening models. The effects of significant 
factors on five different responses were studied by generating RSMs. Central Composite 
Designs (CCDs) with on-face axial points (α=1) and two center points were used to generate 
quadratic RSMs. Only statistically significant model terms (p<0.05) were included in each 
model and were selected using stepwise regression.  
Total soluble protein analysis 
Total soluble protein analysis of clarified lysates was performed using a Nanodrop 1000 
spectrophotometer (Thermo Fisher Scientific; Dartford, UK). Triplicate measurements were 
performed for 3µL sample volumes at an absorbance of 280nm as per manufacturer’s 
instructions. 
TC-HBc analysis with immunoblotting  
[TC-HBc] analysis was conducted using immunoblotting onto nitrocellulose membranes, 
using hepatitis B core-specific antibody (mouse) as a primary antibody and horseradish 
peroxidase-fused, mouse-specific antibody (goat) as a secondary antibody. Details of this 
procedure are described below. 
Clarified samples were diluted in MOPS/EDTA TX100 to achieve total protein 
concentrations of 1mg/mL at a total volume of 50µL in 0.2mL Protein LoBind PCR tubes 
(Cat. No. 951010022). 
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Reference standard, Recombinant Hepatitis B Core Antigen, (Abcam; Cat No. AB49013; 
Cambridge, UK) was diluted in MOPS/EDTA TX100 buffer to achieve 100µL stock 
concentrations of 150µg/mL and 100µg/mL. These stock solutions were serial diluted two-
fold to final volumes of 50µL to generate reference curves. 
5µL 10X NuPage® Sample Reducing Agent was added to all aliquots. These were 
subsequently heated at 95°C for 10 minutes using a Bio-Rad C1000 Touch™ Thermal Cycler 
and subsequently cooled for at least 15 minutes at 12°C.  
For each assay, a 0.45µm 11.5 x 8.5 cm nitrocellulose membranes was placed on a piece of 
filter paper (12 x 9cm) resting on a table. Using a 12 x 8 roster to serve as a grid, samples 
were applied on the membrane in 2µL volumes. Each membrane was dried for at least 10 
minutes at room temperature post sample application. 
After drying, the membranes were blocked in 5% skimmed milk power PBS-T (0.05% 
Tween20) solution for 1 hour at room temperature or overnight at 4-7°C. Hepatitis B virus 
core antigen-specific, mouse monoclonal antibody (Abcam; Cat. No. AB8639; Cambridge, 
UK) was applied in a 1:1000 solution in 2.5% Skimmed Milk Power PBS-T and incubated 
for 45 minutes at room temperature and washed three times for 5 minutes each wash with 
PBS-T. Secondary antibody (Abcam; Cat. No. A4416-1ML; Cambridge, UK) was applied in 
a 1:2000 dilution in PBS-T followed by a 30-minute incubation at room temperature. 
Membranes were finally washed three times for 5 minutes with PBS-T and once for 5 
minutes with PBS to rinse away residual detergent. 10mL of Bio-Rad’s Clarity Western ECL 
substrate was used to develop the membranes. Detection was performed using automated 
exposure setting on an Amersham Imager 600. Dot blot densitometry was done using 
ImageQuant software followed by quantification with four-parameter logistic (4PL) fitting.  
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Microscopy 
Unclarified lysate samples were diluted to [X]=5-10g/L using PBS and stained using a 
1:1000 volumetric addition of boron-dipyrromethene (BODIPY

) in DMSO. After an 
incubation period of 15 minutes, 5µL aliquots of stained suspension were used to prepare 
microscopy slides. Microscopy analysis was done in bright light microscopy and fluorescent 
imaging modes using a Nikon Eclipse microscope. 
Particle Size Distribution Analysis  
PSD analysis was performed using a Malvern Mastersizer 3000. Crude, unclarified, lysate 
was applied to the Hydro SV Dispersion unit at 1000rpm until laser obscuration was in the 5-
10% range. 5 measurements of each sample were taken to subsequently create an average 
PSD curve.  
Results and discussion 
High Pressure Homogenization Optimization 
Figure 3 shows the effect of biomass concentration [X], operating pressure (p) and the 
number of passes (N) on cell disruption (R) expressed as the total amount of soluble total 
protein (mg/mL). The response model can be described with the following formula: R= -
6.14·10
-1
N
2
 -8.92·10
-6
 p
2 
+ 1.38·10
-3
 Np + 1.97·10
-4
 p[X] + 4.20N + 8.4·10
-3
p -1.00·10
-3
[X] -
5.15. 
As indicated by the term 1.97·10
-4
 p[X] the factor interaction of biomass concentration and 
pressure has a positive effect on the level of cell disruption. The term is highly significant 
(p=0.00253) which is in contrast with the assumption made by others 
17
 that the effect of 
biomass concentration on cell disruption is minor. This difference is most likely because 
Follows et al. investigated cell disruption at a significantly higher cell suspension 
concentration range (450-750g/L vs 50-100g/L) where the effect of biomass had diminished. 
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Other literature supports the findings of this research that the concentration of biomass has a 
significant and positive effect on total cell disruption
29
. 
Unlike for pressure, the optimum number of passes seems to stay the same as the biomass 
concentration is changed. This is not surprising as no term for [X]N exists in the equation. 
However, the term 1.38·10
-3
 Np indicates a positive factor-interaction between the number of 
passes and pressure, which is expected.  
Finally, the two quadratic terms of N
2
 and p
2
 indicate optima for pressure and the number of 
passes, however it must be noted that these are quadratic estimates that are only valid within 
the investigated range. The response surface methodology in this series of experiments only 
considers linear or quadratic functions, not for instance, asymptotic functions which are very 
common in biological systems and bioprocesses. Therefore, supposed quadratic optima found 
at the end of the experimental window, could also indicate asymptotic limits. However, 
establishing this would require further work and does not change the main output of this 
study.  
It should also be noted that cell disruption (R) is just one measure of performance in the 
context of cell disruption. As mentioned previously, this paper aims to investigate five 
different performance criteria as response surfaces. Instead of displaying four additional 
response models, figure 3 summarizes the factor settings for various performance optima 
derived from corresponding RSMs. 
Looking at figure 3, one can conclude that different operating conditions are required to 
achieve different maximum performance levels. For instance, maximum pressure (1200 bar) 
is required to achieve maximum cell disruption (R), however sub-maximal pressure (1000 
bar) is preferable for maximum purity (P). Note that in figure 3 biomass is excluded from the 
performance maxima of the response models for specific product recovery (TC-HBCS) and 
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purity (P) as this was found to have insignificant contributions to variance for these specific 
models (p>0.05).   
Adaptive Focused Acoustics Characterization  
Table 1 shows the results of the first screening experiment which was a five-factor, half 
fractorial design was used to generate two factor screenings.  
Biomass ([X]) was found to be the most significant factor for both specific (Rs) and total cell 
disruption (R). However, the magnitude of the range of [X] may have diminished the 
significance of other factors and may therefore not be representative.  
Time, on the other hand, initially seems to be insignificant relative to other factors which was 
in contradiction other sources 
24
. This could be because the effect of time had already 
approached a limit and is not significant within the studied range.  
To account for these two points of discussion, another screening was performed.  In this four-
factor full fractional screening, biomass was fixed at [X]=55g/L so responses R and RS were 
equal. Additionally, the cycles per burst were found to be insignificant. Therefore, in further 
experiments this was fixed at 1000 cpb. The time range was changed to lower exposure times 
as it was hypothesized that longer acoustic exposure times were excessive to achieve 
disruption and would therefore not show as significant contributing to response variance. The 
results of this screening are shown in table 2. Following two screening experiments it was 
found that biomass, duty factor, intensity and acoustic exposure time were significant factors. 
Increasing acoustic exposure time did not have a significant effect beyond 60s. Hence, this 
factor was fixed at this value while other significant factors were varied to generate RSMs in 
optimization experiments.  
Adaptive Focused Acoustics Optimization  
Figure 4 shows how different types of vials, milliTUBE and Chromacol vials, have different 
effects on cell disruption performance. The milliTUBE vials consistently outperformed 
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Chromacol vials for every response. As with homogenization, AFA requires different settings 
depending on the chosen response maxima. For total cell disruption and specific cell 
disruption (see figure 4A) maximum performance values of the milliTUBE configuration 
were found to be slightly higher than that for Chromacol vials. However, the values for 
maximum product recovery and specific recovery (figure 4B) were significantly higher in the 
milliTUBE vials in comparison to Chromacol vials. This in turn, shown by figure 4C, results 
in minimal product purity relative to the milliTUBE configuration since P=[TC-HBc]/R. 
Figure 5, showing RSMs of total cell disruption (R) using milliTUBE and Chromacol vials, 
explains these differences in overall performance. Although AFA-mediated disruption using 
the Chromacol vials does influence disruption within a certain range, as proven by significant 
contribution to variance by the studies factors, it’s effect on overall disruption is most likely 
diminished by other mechanisms such as cell autolysis during fermentation, osmotic shock, 
mechanical stress or heat lysis during buffer resuspension. This is demonstrated in figure 5 by 
a relatively flat response model compared to that of the milliTUBE configuration. 
The underlying mechanism of these differences relate to total vessel volume, total working 
volume and additional mechanical stress through the addition of an AFA fiber in the 
milliTUBE vials. Because the total vessel volume of Chromacol vial is significantly larger 
than that of a milliTUBE vial, acoustic energy is dispersed over a larger volume resulting in 
lower levels of disruption. Additionally, the Chromacol vials used a 17% working volume, 
whereas milliTUBE vials were filled to almost 100%. This difference in relative working 
volumes was a result of standardizing the experiments to absolute working volumes of 1mL. 
Larger relative working volumes lead to more efficient cell disruption processes as acoustic 
energy is directed less to mixing and forming liquid-air interfaces and more towards 
cavitation nucleation in the lysis medium. As higher working volumes reduce mixing rates in 
the sample, the added integrated AFA fiber facilitates the generation of high numbers of 
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uniformly distributed cavitation bubbles. The simultaneously collapse of these high-energy 
liquid-gas interfaces result is higher levels of mechanical energy and thus higher levels of cell 
disruption 
30
. 
This study also addressed the implementation of an enzymatic pre-treatment step into a cell 
disruption process. Several sources report that the enzyme, lyticase, hydrolyses beta-glucans 
in fungal cell walls, resulting in the transformation of cells into so-called protoplasts 
31–33
. 
Lacking cell walls, these protoplasts are much more susceptible to mechanical stress. 
Therefore, cell suspension samples were pre-treated with lyticase to augment subsequent 
AFA-mediated cell disruption.  
Results in figure 4 show that this enzymatic pre-treatment step resulted in significantly higher 
overall performance in AFA-mediated cell disruption compared to the other small-scale 
methods lacking this enzymatic treatment step.  
Anand et al. described how pre-treatment of Escherichia coli cells affected the first order 
disruption rate constant, k, for homogenization
34
. Li et al. subsequently described this rate 
constant in the context of AFA in the following equation at fixed biomass concentration
35
: 
 " 	 =   (4) 
Where Rm is the total maximum available amount of protein available for release. R0 is the 
level of protein release prior AFA-mediated cell disruption and was found to be 4.17mg/mL 
for untreated cells and 16.90mg/mL for enzymatically pre-treated cells ([X]=100g/L). R is the 
observed level of disruption and t is the acoustic exposure time fixed at 60s. 
We did not obtain the absolute value for Rm experimentally but as our purposes are 
comparative, Rm was chosen to be the maximum observed level of protein release from 
homogenization at [X]=100g/L (Rm=29.6mg/mL).  
It was hypothesized that the lyticase pre-treatment step would increase the disruption rate 
constant due to the weakening of cells. However, because of this, it was difficult to determine 
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how much of the observed cell disruption was due to non-mechanical lysis, such as osmotic 
shock, or due to AFA-mediated cell disruption. Using the AFA milliTUBE configuration, we 
found that the disruption rate constant for AFA-mediated disruption preceded by lyticase 
treatment (kLY,AFA= 6.82⋅10
-3
 s
-1
) was 2.65 times higher than the disruption rate constant of 
AFA-mediated cell disruption (kAFA=2.57⋅10
-3
 s
-1
). This strongly suggests that enzymatic pre-
treatment augments performance of AFA-mediated cell disruption by weakening cells.  
Because of this pre-treatment, maximum levels of AFA-mediated cell disruption almost 
matched maximum levels achievable with HPH. Moreover, the performance of the 
augmented AFA method for maximum specific product recovery was superior to that of 
HPH. Likewise, as shown in figure 4C, both platforms using milliTUBEs achieved higher 
product purity levels than HPH. 
Just as HPH requires different operating settings depending on the response studied, AFA 
optima settings depend on the choice of performance criteria and the mode of AFA (figure 
4D).  
Product recovery  
The previous section demonstrated the differences in various response between HPH and 
various modes of AFA. This section aims to explain the mechanisms involved behind the 
performance of the discussed cell disruption methods.   
Figure 6A shows Particle Size Distribution (PSD) curves of various unclarified lysates from 
disrupted samples. The amount of micronized debris (less than 1µm) generated through HPH 
is much higher than that generated through AFA-mediated disruption. These high levels of 
micronized debris are associated with high levels of cell disruption, however also impede 
recovery of product. This is demonstrated in figure 6B where HPH is shown to lead to lower 
product purities than AFA despite higher levels of cell disruption.  
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Interestingly, the enzymatic pre-treatment step did not lead to a significant change in PSD 
even though it significantly increased levels of cell disruption. This is probably why the 
maximum purity level of milliTUBE AFA-mediated disruption is comparable to that of 
milliTUBE AFA-mediated disruption preceded by lyticase treatment. 
The generation of micronized debris during HPH (figure 6A) can lead to the subsequent 
formation of aggregates as seen in figure 7A. The fluorescent BODIPY stain shows neutral 
lipids in intact cells that were adhered together by cell debris. Such aggregation can severely 
limit the release of the hydrophilic product into the supernatant upon subsequent clarification.  
In contrast, AFA-mediated cell disruption does not seem to generate micro debris. As shown 
in figure 7B, a cell disrupted by AFA releases its lipid content out of the cell wall without 
forming large aggregates. Similar results are observed in figure 7C, showing a lyticase treated 
sample that is subsequently disrupted using AFA (figure 7D).   
Process scaling and cell disruption mimicry 
So far, this paper has made multiple comparisons between the relatively large-scale industry 
standard of cell disruption, HPH, and various modes of small-scale, non-contact AFA 
methods.   
For some performance criteria, we have found that it is possible for AFA to outperform HPH.  
However, when scaling down a process, the goal is often not to outperform the large-scale 
surrogate but to mimic its performance as close as possible. To achieve this, one must define 
these performance criteria. 
This study considered a scenario where the objective was to maximize product purity from a 
homogenization process and, using enzyme-augmented AFA, mimic both the level of purity 
and the corresponding level of product recovery at the same homogenization parameter 
settings.  
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First, operating ranges were defined by determining standard deviation windows of (1) 
maximum product purity, P, and (2) the corresponding level of product recovery, [TC-HBc], 
at maximum purity of HPH.  
Overlaying the purity and product recovery response functions for enzymatically augmented 
AFA, at the specified ranges, yielded the operating domains for duty factor and intensity 
settings. The corresponding operating window is displayed in white in figure 8.  
It should be noted that the above scenario serves as an example of how the proposed scale-
down methods can be implemented to mimic any large-scale cell disruption process. By 
assigning multiple performance criteria we can achieve more defined conditions to mimic 
performance at small-scale. Likewise, the same methodology can be applied to scale-up a 
micro-scale cell disruption process. We therefore believe that the scale-down AFA-mediated 
cell disruption can be used in a wide array of applications such as high-throughput buffer 
development and micro-scale fermentation sampling whilst retaining scalable significance. 
Conclusions  
This paper presents the development of a high-performance, high-throughput small-scale, 
scalable disruption tool for microbial bioprocess development. This was done by 
investigating five performance criteria in four modes of cell disruption. One of these modes 
involved the use of the industry standard of cell disruption, High Pressure Homogenization, 
and the other three involved various modes of operation of small-scale, non-contact Adaptive 
Focused Acoustics methods. These investigations were carried out through statistical 
screening methods, the development of twenty response surface models, various modes of 
microscopy and particle size distribution analysis.  
Significant process parameters for AFA were found to be acoustic exposure time, biomass 
suspension concentration, duty factor and intensity. After performing optimization 
experiments for these significant factors, it was found that the design of the vessel in which 
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samples were sonicated had a great impact on all cell disruption performance criteria. 
Specifically, it was found that the use milliTUBE vials greatly enhanced performance 
compared to using Chromacol vials. Performance was subsequently augmented using an 
enzymatic pre-treatment step. This led to matching and even outperforming homogenization 
performance, depending on the performance criterion investigated. The resulting overlap of 
performance ranges between HPH and AFA-mediated cell disruption allowed for small-scale 
AFA performance mimicry of HPH. Performance mimicry was enhanced by matching 
multiple performance criteria, as opposed to a single criterion, using overlay plot analysis. 
These results demonstrate that AFA-mediated cell disruption could be used as a tool for a 
wide variety of applications including buffer development, strain selection, fermentation 
process development and whole bioprocess integration. 
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Nomenclature 
[TC-HBc]: Product concentration / product recovery / Tandem Core Hepatitis B 
concentration 
[X]: Biomass concentration 
AFA: Adaptive Focused Acoustics 
CER: Carbon Evolution Rate 
Cpb: Cycles per Burst 
DF: Duty Factor 
DoE: Design of Experiments 
DOT: Dissolved Oxygen Tension 
HPH: High Pressure Homogenization 
LY: Lyticase 
mTUBE: milliTUBE 
P: Product purity 
PBS: Phosphate Buffered Saline 
PSD: Particle Size Distribution 
R: Cell disruption / protein release 
RO: Reverse Osmosis 
Rs: Specific cell disruption / specific protein release 
RSM: Response Surface Methodology or Response Surface Model 
RSME: Root Mean Square Error 
TC-HBc: Tandem Core Hepatitis B core protein 
TC-HBcs:  Specific product recovery  
VLP: Virus-Like Particle 
WCW: Wet Cell Weight 
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Tables 
Table 1:  Relative factor contributions in a five factor, two-level, half fractional factorial 
screening designs 
Factor DF (%) cpb I (mv) t (s) [X] (g/L) 
Range (0.1,20) (50,1000) (0.1,10) (60,300) (10,100) 
% contribution Total disruption (R) 23.5% 8.6% 9.9% 8.7% 49.1% 
Specific disruption (RS) 1.6% 0.1% 0.3% 0.3% 97.7% 
 
Two different screenings were performed: One for R and one for Rs. 
 
Table 2:  Relative factor contributions in a four-factor, two-level, full-fractional factorial 
screening design 
Factor DF (%) cpb I (mv) t (s) 
Range (0.1,20) (50,1000) (0.1,10) (10,60) 
% contribution Total cell disruption (R=RS) 40.1% 0.4% 38.4% 21.1% 
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Figures 
 
Figure 1: Covaris components and parameters. (A1) Tank containing cooled degassed 
deionized water, (A2) acoustic transducer, (A3) vial containing suspended cells and (A4) 
acoustic focal zone. (B) Covaris parameters: Duty Factor, DF (%), refers to the relative time 
between sonic bursts, hence #$ = %1 %2  ∙ 100%. Intensity, I (mV), denotes the amplitude 
of the sonic wave. Cycles per burst, cpb, refers to the amount of cycles per acoustic wave. In 
this case, cpb is 4. Time, t (s), simply refers to the total time a sample is exposed to 
sonication treatment. [X] (g/L) refers to the wet cell biomass concentration in suspension.  
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Figure 2: Process overview of experimental methods. (A) P.pastoris fermentation. (B) 
Harvest centrifugation at 3000 g, 20 min, 4°C. (C1) HPH of resuspended pellet at T=8±2°C 
and variable p, N and [X]. (C2) AFA of resuspended pellet at T=9±1°C and variable I, DF, 
cpb and t using either 1mL milliTUBE vials or 6mL Chromacol vials. (C3) Lyticase pre-
treatment of resuspended pellet (25°C, 1h) followed by AFA at T=9±1°C and variable I, DF, 
cpb and t using 1mL milliTUBE vials. (D) Clarification centrifugation of crude lysate at 
15000 g, 30min, 4°C. (E) Dead-end filtration (0.22µm) of supernatant.  
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Figure 3: High Pressure Homogenization performance. (A and B) Response Surface 
Models at different level of [X] for total cell disruption measured as total soluble protein, R 
(mg/mL). (C) Factor values and optima for various responses: R (r
2
=0.98), RS (r
2
=0.97), [TC-
HBc] (r
2
=0.92), TC-HBcS (r
2
=0.90) and P (r
2
=0.77).  
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Figure 4: Summary of Response Surface Models for Adaptive Focused Acoustic 
methods. (A-C) Maximum response ranges for various performance criteria. (A) On the left 
y-axis, the level of total cell disruption (R); on the right y-axis, the specific level of cell 
disruption (Rs). (B) On the left y-axis the level of total product recovery ([TC-HBc]); on the 
right y-axis, the specific level of product recovery (TC-HBcs). (A, B) The horizontal grid 
lines display the maximum model ranges of the studied responses of High Pressure 
Homogenization (HPH). (C) Purity (P) performance ranges. (D) Different factor values to 
achieve optima. Intensity values are superimposed over duty factor values. 
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Figure 5: Effect of vial design. Response Surface Models at [X]=100g/L WCW and t=60s 
for two configurations of AFA-mediated cell disruption. (1) Using 6mL Chromacol vials: (2) 
1mL milliTUBE vials with integrated acoustic fibres. 
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Figure 6: Effect of micronized debris on purity. (A) PSD analysis of untreated cells in 
suspension ([X]=50g/L) and respective crude lysates disrupted by homogenization (p=1200 
bar, N=5 passes, T=8±2°C), AFA (I=10mV, DF=20%, cpb=1000, t=60s, T=9±1°C) and AFA 
preceded by lyticase incubation (t=1hr, T=25°C). (B) Modelled quantitative analysis of 
clarified lysates disrupted by AFA, AFA preceded by lyticase incubation and 
homogenization. Two levels of cell disruption (R) and product purity (P) are given: the 
maximum values of the respective Response Surface Models (Rmax, Pmax) and, superimposed, 
the levels of disruption and purity (Rat PSD, Pat PSD) achieved at the same disruption conditions 
represented by the PSD curves. Error bars correspond to performance maxima only.  
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Figure 7: Impact of cell disruption method on cell debris and aggregation. Microscopy 
images of lysates ([X]=50g/L) at 101.5x magnification. (A1) Bright light microscopy image 
of homogenized sample (p=1200 bar, N=5 passes, T=8±2°C) and (A2) corresponding 
fluorescent image showing lipid content. (B1, B2) AFA (I=10mV, DF=20%, cpb=1000, 
t=60s, T=9±1°C). (C1, C2) Lyticase pretreated sample. (D1, D2) Lyticase pretreated sample 
followed by AFA mediated disruption (I=10mV, DF=20%, cpb=1000, t=60s, T=9±1°C). 
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Figure 8: Microscale process mimicry. Overlay plot of enzymatically augmented AFA-
mediated cell disruption funcions of purity, F(PAUG. AFA), and product recovery, F([TC-
HBc]AUG.AFA) at [X]=50 g/L and t=60s. 
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